Skip to content

Is Cognitive Behavioural Therapy for Alcohol Dependence Treatment more effective if tailored for individual patient needs?

Twelve week abstinence outcomes of alcohol dependent patients undergoing Cognitive Behavioural Therapy (CBT) that targets and profiles psychological risk versus generic Cognitive Behavioural Therapy (CBT).

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000865718
Acronym
Nil
Enrollment
379
Registered
2013-08-05
Start date
2014-01-06
Completion date
2017-02-03
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This randomised control trial (RCT) investigates whether targeting specific psychological drinking profiles in alcohol dependent patients is clinically more effective than generic psychological treatment.

Interventions

Psychological Intervention: A 45 minute assessment with standardised psychometric tools measuring alcohol expectancy (Drinking Expectancy Profile), drinking refusal self-efficacy (Drinking Refusal Self-Efficacy Questionnaire), craving (Alcohol Craving Questionnaire, Obsessive-Compulsive Drinking Scale), impulsivity (Dickman Impulsivity Inventory), dependence (Severity of Alcohol Dependence Scale, Brief MAST, Alcohol Use Identification Test) and general mental health functioning (General health

Psychological Intervention: A 45 minute assessment with standardised psychometric tools measuring alcohol expectancy (Drinking Expectancy Profile), drinking refusal self-efficacy (Drinking Refusal Self-Efficacy Questionnaire), craving (Alcohol Craving Questionnaire, Obsessive-Compulsive Drinking Scale), impulsivity (Dickman Impulsivity Inventory), dependence (Severity of Alcohol Dependence Scale, Brief MAST, Alcohol Use Identification Test) and general mental health functioning (General health Questioniare-28, Beck Depression Inventory-II, State-Trait Anxiety Inventory, Toronto Alexithymia Scale) will be used to profile psychological risk of each patient. Risk is determined by previous published studies and historical data from the trial site. Cognitive Behavioural Therapy (CBT) treatment manuals that target these key deficits/excesses will be developed. These manuals will be administered by clinical psychologists (x4 one hour weekly sessions first 4 weeks, x4 fortnightly 1 hour sessions next 8 weeks= 12 week program, with 8 x 1 hour sessions). Treatment attendance will be recorded and patients will be breathalyzed prior to each treatments session. Carbohydrate-deficient transferrin (CDT) testing is available to validate self-report, if indicated. DNA will also be donated from consenting patients, but will not form part of the current intervention. These de-identified data will be used to construct genetic risk models in subsequent trials

Sponsors

A/Prof Jason Connor
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Consecutively treated patients who meet established criteria for alcohol dependence.

Exclusion criteria

- Current dependence on substances other than alcohol (except nicotine) - Current disulfiram use - Prescribed opioids

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026